Am J Transplant, Volume 17, Suppl 3 Archives - Page 163 of 181 - ATC Abstracts

2017 American Transplant Congress
A2 Incompatible Kidney Transplantation: A Single Center Experience.
L. Kamal, M. Ajaimy, M. Lubetzky, G. DeBoccardo, P. Bedi, S. Greenstein, J. Rocca, J. Graham, M. Kinkhabwala, A. Chokechanachaisakul, A. Courson, E. Akalin.
Montefiore Medical Center Transplant Center, Albert Einstein College of Medicine, NY
Background: The new kidney allocation system implemented in December 2014 allowed for use of A2/A2B donors to B recipients. However there is no mandate by…
2017 American Transplant Congress
Eculizumab Treatment on GC3 Recurrence on Renal Graft.
G. Jeantet,¹ D. Bertrand,³ A. Lionet,² D. Anglicheau,⁴ V. Fremeaux-Bacchi,⁵ M. Le Quintrec.¹
¹Department of Nephrology, Dialysis and Transplantation, Hôpital Lapeyronie, Montpellier University Hospital, Montpellier, France; ²Department of Nephrology, Dialysis and Transplantation, Lille, France; ³Department of Nephrology, Dialysis and Renal Transplantation, Rouen, France; ⁴Transplantation Rénale, Necker Hospital, Paris, France; ⁵Immunology, Hopital Européen Georges Pompidou, Paris, France
Clinical C3G recurrence occured in more than 50% after renal transplantation and is the first cause of allograft loss at 5 years post-transplantation. Eculizumab (EC)…
2017 American Transplant Congress
Course of Donor Specific Anti-HLA Antibodies After Induction Therapy with Rituximab in Renal Transplantation.
M. Baas,¹ W. Allebes,² M. van den Hoogen,³ I. Joosten,² L. Hilbrands.¹
¹Nephrology, Radboud University Medical Center, Nijmengen, Netherlands; ²Blood Transfusion and Transplantation Immunology, Radboud University Medical Center, Nijmegen, Netherlands; ³Internal Medicine, Division of Nephrology and Kidney Transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands
The presence of pre-existing or de novo donor-specific antibodies against HLA (DSA), is associated with a worse graft outcome after renal transplantation. B-cell depletion protocols…
2017 American Transplant Congress
The Impact of Induction Therapy on Delayed Graft Function Following Kidney Transplantation in Mated Kidneys.
T. Butler, N. Hayde.
Department of Transplantation, Albert Einstein-Montefiore, Bronx, NY
Purpose: Delayed graft function (DGF) is defined as the need for dialysis within one week of transplantation and occurs in 20-50% of deceased-donor kidney transplant…
2017 American Transplant Congress
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.
M. Safwan,¹ M. Abouljoud,¹ R. Salgia.²
¹Divison of Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; ²Gastroenterology, Henry Ford Hospital, Detroit, MI
Aim: To study outcomes of liver transplantation (LT) patients with prior bariatric surgery (BS).Methods: Retrospective analysis performed on patients with LT between Jan 2006 and…
2017 American Transplant Congress
Pre-Operative Desensitization for Live Donor Liver Transplantation with Strong Donor-Specific Antibodies.
M. Fujiki,¹ K. Hashimoto,¹ A. Zhang,² F. Aucejo,¹ C. Quintini,¹ T. Diago,¹ B. Eghtesad,¹ C. Miller.¹
¹General Surgery, Cleveland Clinic, Cleveland, OH; ²Allogen Laboratories, Cleveland Clinic, Cleveland, OH
Background: Presence of strong donor-specific antibodies (DSA) (MFI>4000) likely results in uncomplicated short-term outcome in whole liver transplants due to absorption of DSA by the…
2017 American Transplant Congress
Heterotopic Auxiliary Liver Transplantation(ALTx) – Revisited.
V. Kirchner, E. Minja, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
University of Minnesota, Minneapolis
Background:Although, ALTx for acute liver failure(ALF) has been described over 30yrs ago, utilization of operation has been limited. Benefit of operation is to provide bridge…
2017 American Transplant Congress
Is the Time of Appearance and Resolution of De Novo HLA-DP Donor Specific Antibodies Associated with Reduced Deleterious Effect on Lung Transplant Outcomes?
A. Zhang,¹ Y. Sun,² K. McCurry,³ M. Budev.³
¹Allogen Laboratories, Cleveland Clinic, Cleveland, OH; ²Avalon University School of Medicine, Willemstad, Netherlands Antilles; ³Transplantation Center, Cleveland Clinic, Cleveland, OH
Introduction: The impact of HLA-DP de novo donor specific antibodies (dDSA) to lung transplantation (LT) is poorly understood. This study analyzed the association of timely…
2017 American Transplant Congress
Biliary Complications After Pediatric Liver Transplantation: A High Volume Living Donor Liver Transplantation Center Study of 237 Patients Over 27 Years.
D. Oh,¹ N.-J. Yi,¹ S. Ahn,¹ S. Hong,¹ K. Yoon,¹ H.-S. Kim,¹ H. Kim,¹ K.-W. Lee,¹ K.-S. Suh,¹ J. Han,² M. Kim,² J. Lee.²
¹Surgery, Seoul National University College of Medicine, Seoul, Korea; ²Radiology, Seoul National University College of Medicine, Seoul, Korea
Background. Biliary complication (BC) is prevalent in pediatric liver transplantation (PLT), with reported rates from 12% to 50%. This study analyzed which factors of perioperative…
2017 American Transplant Congress
Digital Image Analysis of Pediatric Liver Allograft Biopsies Correlates with METAVIR Fibrosis Score.
R. Fischer,¹ S. Foster,² J. Daniel,¹ R. Hendrickson,¹ W. Andrews,¹ A. Kats.¹
¹Children's Mercy Hospital, Kansas City, MO; ²University of Kansas Medical Center, Kansas City, KS
Background: Serial surveillance biopsies demonstrate post-transplant inflammation and fibrosis in long-surviving pediatric liver allografts. These changes can ultimately lead to cirrhosis and graft failure. However,…